Back to search
Vasomotor Symptoms
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vasomotor Symptoms trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vasomotor Symptoms trials you may qualify forThe purpose of this study is to find out if patients with prostate cancer who have vasomotor symptoms, commonly called hot flashes, from their Androgen Deprivat…
This is a phase II, randomized, double-blinded, placebo-controlled trial designed to evaluate the efficacy of fezolinetant (45 mg a day) vs. placebo in reducing…
The purpose of this study is to evaluate the effects of single and multiple doses of ABCL635 administered by subcutaneous (SC) injection to healthy men and to p…
This is an observational study to learn more about vasomotor symptoms (VSM) burden and treatment patterns in menopausal women before and after participating in…
The aim of this clinical trial is to determine if resistance training and a newly developed plant-based nutritional supplement can improve the symptoms and musc…
The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.
Researchers are looking for a better way to treat women with, or at high risk for developing hormone-receptor positive breast cancer, who have vasomotor symptom…
This phase II trial tests how well fezolinetant works in improving vasomotor symptoms (VMS) in breast cancer patients taking endocrine therapy (ET). Anti-hormon…